Melanocortin and dermal research
Melanotan I
Lyophilized dermal or melanocortin research peptide
Melanotan I / afamelanotide is an alpha-MSH analog research peptide tied to melanocortin receptor and pigment biology literature.
Support can confirm any currently available COAs or batch documentation for this product.
Request available documentsConfirm an optional email signup to receive a single-use 10% welcome code.
Get catalog updatesFor laboratory research use only. Not for human or veterinary use. Not intended to diagnose, treat, cure, mitigate, or prevent disease.
Keep sealed, cold, dry, and protected from heat swings. Confirm product-specific storage on arrival.
Packed for transit stability with order support available for warm-weather routes.
Batch-linked certificate support is available through the documentation desk.
शोध संदर्भ
Melanotan I शोध प्रोफ़ाइल
Melanotan I is an alpha-melanocyte-stimulating hormone analog closely associated with the afamelanotide research lineage. It is studied primarily through melanocortin 1 receptor activity, cyclic-AMP signaling, melanogenesis, pigment-cell biology, and photobiology models. Compared with Melanotan II, its research profile is more closely centered on pigment pathways and MC1R rather than broad activity across several melanocortin receptors. It is selected when a study requires an alpha-MSH analog for melanocyte or receptor-selectivity work. Literature on approved afamelanotide products and clinical formulations does not establish the identity, approval, sterility, or intended use of a separate research catalog material.
Molecular class
13-residue alpha-MSH analog
Sequence / composition
An acetylated alpha-MSH-derived sequence containing norleucine and D-phenylalanine substitutions.
Research design note
Its construct is generally studied for MC1R-focused pigment biology rather than the broader receptor profile of Melanotan II.
प्रस्तावित तंत्र
An alpha-MSH analog that activates melanocortin 1 receptors on melanocytes, stimulating adenylate cyclase, cyclic AMP, MITF-related transcription, tyrosinase activity, and eumelanin production.
अध्ययनों में बताए गए प्रभाव
- Cell and human afamelanotide studies report increased melanin production and pigmentation-related measures.
- Clinical studies of regulated afamelanotide formulations report improved phototolerance in specific photosensitivity disorders.
- Pigment changes, nevi monitoring, nausea, headache, and formulation-specific adverse events are relevant observations.
सामान्य शोध एंडपॉइंट
MC1R potency, cyclic AMP, MITF, tyrosinase, melanin content, skin reflectance, phototolerance, pigment distribution, nevus changes, pharmacokinetics, and adverse events.
साक्ष्य और सीमाएँ
Mechanistic and regulated-product human evidence exists for afamelanotide. Catalog research material is not represented as an approved implant or cosmetic product.
External reading
Literature for context—not product proof.
Third-party sources describe their own research materials and methods. They do not validate a specific Azure catalog batch.
Support and documentation
Questions about this product?
Where can I find product documentation?
Contact support with the product name and any relevant order or batch reference to request available documents.
How can I compare pack options?
Where multiple pack sizes are available, Azure shows the price per listed vial so you can compare catalog value directly.